首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到10条相似文献,搜索用时 31 毫秒
1.
Objective To investigate immunomodulatory effect of Astragalus polysaccharides (APS) on IL-12-secreting dendritic cell (DC) subset CD11chigh CD45RBlow DC. Methods Spleen CD11chighCD45RBlow DC and CD4 +T lymphocytes in BALB/c mice were purified by magnetic beads sorting,and were treated with 0 (as control), 50, 100, 200 μg/mL APS. Immunofluorescence staining and flow cytometry were used to determine expressions of CD11chighCD45RBlow DC surface molecules, including CD40,CD80, CD86, I-A/E, and Toll-like receptor (TLR) 4. IL-12 level in CD11chighCD45RBlow DC culture supernatant was determined by ELISA. The CD4+ T lymphocytes were divided into: normal control group,non-stimulation group ( CD4 + T lymphocytes cocultured with APS-unstimulated CD11 chigh CD45RBlow DC ) ,high-dose APS stimulation group (CD4+T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11ch'ghCD45RBlow DC) , high-dose APS stimulation + antibody 1 group ( CD4 + T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11chighCD45RBlow DC and IL-12 antibody), high-dose APS stimulation +antibody 2 group (CD4 +T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11chigh CD45RBlow DC and IL-12 antibody isotype). Proliferation ability of CD4 + T lymphocytes was determined with MTT method.IL-4 level as well as IFN-γ level in CD4 + T lymphocyte culture supernatant was determined by flow cytometry. Data were processed with one-way analysis of variance. Results Compared with those in control, the expressions of CD 11 chigh CD45 RBlow DC surface molecules ( except for CD86 ) on CD 11 chigh CD45RBlow DC surface, as well as IL-12-secreting level with dose-dependence were increased in cells stimulated with 50,100, 200 μg/mL APS. Proliferation ability of CD4 +T lymphocytes in high-dose APS stimulation group was higher as compared with that in non-stimulation group ( F = 13. 438, P <0.05). IFN-γlevel in high-dose APS stimulation group [(2784 ± 137 ) pg/mL] was higher than that in non-stimulation group [(1952 ±101 ) pg/mL, F = 12. 177, P <0.05]. IL-4 level in high-dose APS stimulation group was (172 t 20) pg/mL,which was lower than that in non-stimulation group [( 193 ± 19) pg/mL, F = 11.963, P <0.05]. Proliferation ability of CD4+ T lymphocytes, IFN-γ level, and IL-4 level in high-dose APS stimulation + antibody 1 group were all ameliorated when compared with those in non-stimulation group; while levels of the 3 indexes in high-dose APS stimulation + antibody 2 group were similar to those in high-dose APS stimulation group.Conclusions APS can activate IL-12-producing CD11 chighCD45RBlowDC, and further induce the activation of immune function of T lymphocyte with shifting of Th2 to Th1 in vitro. APS can enhance the immune response via promoting the phenotypic and functional maturation of CD11 chighCD45RBlow DC.  相似文献   

2.
目的 观察黄芪多糖(APS)对分泌IL-12树突细胞(DC)亚群CD11chighCD45RBlowDC功能的影响.方法磁珠分选技术获得BALB/c小鼠脾脏CD11chighCD45RBlowDC和CD4+T淋巴细胞.在CD11 chighCD45RBlowDC中加入不同浓度APS(50、100、200μg/mL)处理,以不加APS的细胞作为对照,应用ELISA法检测细胞培养上清液中IL-12水平,流式细胞仪检测细胞表面分子CD40、CD80、CD86、I-A/E及Toll样受体4(TLR4)的表达.将CD4+T淋巴细胞分为正常对照组(未行任何处理)、未刺激组(加入未经APS处理的CD11chighCD45RBlowDC与CD4+T淋巴细胞混合培养)、高浓度APS刺激组(加入经200μg/mL APS处理后的CD11chighCD45RBlowDC与CD4+T淋巴细胞混合培养)、高浓度APS刺激+抗体1组(加入经200μg/mL APS处理后的CD11chighCD45RBlowDC、IL-12抗体与CD4+T淋巴细胞混合培养)和高浓度APS刺激+抗体2组(加入经200 μg/mL APS处理后的CD11chighCD45RBlowDC、IL-12同型对照抗体与CD4+T淋巴细胞混合培养).采用噻唑蓝法测定CD4+T淋巴细胞增殖能力,流式细胞仪检测细胞培养液中IL-4和γ干扰素水平.对数据行多组间单因素方差分析.结果与未加APS刺激相比,3种浓度APS均显著增强CD11chighCD45RBlowDC表面分子CD40、CD80、I-A/E及TLR4表达及IL-12分泌,其中IL-12分泌呈APS浓度依赖性;CD86表达无明显变化.高浓度APS刺激组CD4+T淋巴细胞增殖能力高于未刺激组(F=13.438,P<0.05);高浓度APS刺激组细胞γ干扰素水平为(2784±137)pg/mL,高于未刺激组[(1952±101)pg/mL,F=12.177,P<0.05];高浓度APS刺激组细胞IL-4水平为(172±20)pg/mL,明显低于未刺激组[(193±19)pg/mL,F=11.963,P<0.05].高浓度APS刺激+抗体1组前述3项指标表达水平较未刺激组明显改善,高浓度APS刺激+抗体2组前述3项指标表达水平与高浓度APS刺激组接近.结论 APS能够通过促进CD11chighCD45RBlowDC中IL-12的表达,诱导CD4+T淋巴细胞向Th1型反应分化,通过激活CD11chighCD45RBlowDC增强免疫活性.
Abstract:
Objective To investigate immunomodulatory effect of Astragalus polysaccharides (APS) on IL-12-secreting dendritic cell (DC) subset CD11chigh CD45RBlow DC. Methods Spleen CD11chighCD45RBlow DC and CD4 +T lymphocytes in BALB/c mice were purified by magnetic beads sorting,and were treated with 0 (as control), 50, 100, 200 μg/mL APS. Immunofluorescence staining and flow cytometry were used to determine expressions of CD11chighCD45RBlow DC surface molecules, including CD40,CD80, CD86, I-A/E, and Toll-like receptor (TLR) 4. IL-12 level in CD11chighCD45RBlow DC culture supernatant was determined by ELISA. The CD4+ T lymphocytes were divided into: normal control group,non-stimulation group ( CD4 + T lymphocytes cocultured with APS-unstimulated CD11 chigh CD45RBlow DC ) ,high-dose APS stimulation group (CD4+T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11ch'ghCD45RBlow DC) , high-dose APS stimulation + antibody 1 group ( CD4 + T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11chighCD45RBlow DC and IL-12 antibody), high-dose APS stimulation +antibody 2 group (CD4 +T lymphocytes cocultured with 200 μg/mL APS-stimulated CD11chigh CD45RBlow DC and IL-12 antibody isotype). Proliferation ability of CD4 + T lymphocytes was determined with MTT method.IL-4 level as well as IFN-γ level in CD4 + T lymphocyte culture supernatant was determined by flow cytometry. Data were processed with one-way analysis of variance. Results Compared with those in control, the expressions of CD 11 chigh CD45 RBlow DC surface molecules ( except for CD86 ) on CD 11 chigh CD45RBlow DC surface, as well as IL-12-secreting level with dose-dependence were increased in cells stimulated with 50,100, 200 μg/mL APS. Proliferation ability of CD4 +T lymphocytes in high-dose APS stimulation group was higher as compared with that in non-stimulation group ( F = 13. 438, P <0.05). IFN-γlevel in high-dose APS stimulation group [(2784 ± 137 ) pg/mL] was higher than that in non-stimulation group [(1952 ±101 ) pg/mL, F = 12. 177, P <0.05]. IL-4 level in high-dose APS stimulation group was (172 t 20) pg/mL,which was lower than that in non-stimulation group [( 193 ± 19) pg/mL, F = 11.963, P <0.05]. Proliferation ability of CD4+ T lymphocytes, IFN-γ level, and IL-4 level in high-dose APS stimulation + antibody 1 group were all ameliorated when compared with those in non-stimulation group; while levels of the 3 indexes in high-dose APS stimulation + antibody 2 group were similar to those in high-dose APS stimulation group.Conclusions APS can activate IL-12-producing CD11 chighCD45RBlowDC, and further induce the activation of immune function of T lymphocyte with shifting of Th2 to Th1 in vitro. APS can enhance the immune response via promoting the phenotypic and functional maturation of CD11 chighCD45RBlow DC.  相似文献   

3.
Objective To explore the impact of interleukin (IL) -17 expression on tumor growth in experimental models of murine mammary carcinoma and potential mechanisms. Methods Two murine cell lines, MA782/5S28102 and 4T1 were used to establish experimental models of murine mammary carcinoma. The IL-17 expression in tumor tissues derived from MA782-bearing mice or 4T1-bearing mice was detected in early and late stages of the tumor by Western blotting. The tumor cells and tumor-infiltrated-lymphocytes were separated from tumor tissues and cultured for 5 days with stimulation of PMA, anti-CD3 antibody and anti-CD28 antibody. The supernatants of culture media of stimulated tumor cells or tumor-infiltrated-lymphocytes were harvested and tested for IL-17 concentration by enzyme linked immunosorbent assay (ELISA). To evaluate the effect of IL-17 on the proliferation of tumor cells, 4T1 cells were culture in media with or without IL-17 and the cell number was counted on the day 5. For ire vivo assay, 4T1-bearing mice were injected with IL-17 or culture media via tail vein, and the tumor volume was measured. To assay the angiogenesis, the tumor tissues from 4T1-bearing mice with or without injection of IL-17 were stained with anti-CD31 antibody by immunohistochemistry. Results The IL-17 expression was significantly higher in late stage than in early stage of tumor in two experimental models. The tumor expression of IL-17 was secreted by tumor infiltrated lymphocytes (P <0.01). IL-17 could not increase the generation of tumor cells in vitro (1. 11 ±0. 11, 1. 28 ±0. 21 ,P >0. 05). But IL-17, injected into 4T1 -bearing mice, markedly enhanced in vivo tumor growth and significantly increased tumor vascularity (35. 79 ±9. 49, 13. 52 ±3. 55,P <0.01). Conclusion IL-17 in tumor tissue probably promotes tumor growth through enhancing angiogenesis.  相似文献   

4.
Objective To investigate the relationship between CD4-CD8-T cells ratio and IL-4, IFN-γ levels in the peripheral blood of patients with pancreatic carcinoma. Methods Floweytometer was used to analyze the CD4-CD8-T cells ratio in the peripheral blood of patients with pancreatic carcinoma and the IL-4 ,IFN-γ levels were detected by ELISA. Results The ratio of CD4-CD8-T cell in CD3+ T cell from 25 pancreatic carcinoma patients was(4.2 ± 1.7) %, the ratio of CD4-CD8-T cell in CD3+T cell from 45 healthy person was(6.3 ± 2.6) %, there was significant deviation between the two groups(P < 0. 01). The IL-4 level of 25 pancreatic carcinoma patients was (86.3 ± 23.3) fg/L,the IL-4 level of 45 healthy person was (56.2 ± 9.2) fg/L,there was significant deviation between the two groups(P <0.01). The IFN-γ level of 25 pancreatic carcinoma patients was (16.4±4.8) fg/L before operation, the IFN-γ level of 45 healthy person was (27.4±3.8) fg/L,there was significant deviation between the two groups(P <0.01). The ratio of CD4-CD8-T cell in pancreatic carcinoma patient after operation was higher than before operation. It could be found negative correlation between CD4-CD8-T cells ratio and IL-4 level in pancreatic carcinoma patient,it could also be found positive correlation between CD4-CD8-T cells ratio and IFN-γ level in pancreatic carcinoma patient. In pancreatic carcinoma patient,the CD4-CD8-T cells ratio and IL-4 level was significant associated with clinical stage (P < 0.05), but no relationship with hisological differentiation (P>0.05), it could be found no relationship between IFN-γ level and clinical stage, hisoiogieal differentiation (P > 0.05). Conclusion The CD4±CD8±T cells ratio in the peripheral blood of patients is decreased,it may be participate in the carcinogenesis and development of pancreatic carcinoma by influence the IFN-γ levels.  相似文献   

5.
Objective To investigate the relationship between CD4-CD8-T cells ratio and IL-4, IFN-γ levels in the peripheral blood of patients with pancreatic carcinoma. Methods Floweytometer was used to analyze the CD4-CD8-T cells ratio in the peripheral blood of patients with pancreatic carcinoma and the IL-4 ,IFN-γ levels were detected by ELISA. Results The ratio of CD4-CD8-T cell in CD3+ T cell from 25 pancreatic carcinoma patients was(4.2 ± 1.7) %, the ratio of CD4-CD8-T cell in CD3+T cell from 45 healthy person was(6.3 ± 2.6) %, there was significant deviation between the two groups(P < 0. 01). The IL-4 level of 25 pancreatic carcinoma patients was (86.3 ± 23.3) fg/L,the IL-4 level of 45 healthy person was (56.2 ± 9.2) fg/L,there was significant deviation between the two groups(P <0.01). The IFN-γ level of 25 pancreatic carcinoma patients was (16.4±4.8) fg/L before operation, the IFN-γ level of 45 healthy person was (27.4±3.8) fg/L,there was significant deviation between the two groups(P <0.01). The ratio of CD4-CD8-T cell in pancreatic carcinoma patient after operation was higher than before operation. It could be found negative correlation between CD4-CD8-T cells ratio and IL-4 level in pancreatic carcinoma patient,it could also be found positive correlation between CD4-CD8-T cells ratio and IFN-γ level in pancreatic carcinoma patient. In pancreatic carcinoma patient,the CD4-CD8-T cells ratio and IL-4 level was significant associated with clinical stage (P < 0.05), but no relationship with hisological differentiation (P>0.05), it could be found no relationship between IFN-γ level and clinical stage, hisoiogieal differentiation (P > 0.05). Conclusion The CD4±CD8±T cells ratio in the peripheral blood of patients is decreased,it may be participate in the carcinogenesis and development of pancreatic carcinoma by influence the IFN-γ levels.  相似文献   

6.
Objective To investigate the relationship between CD4-CD8-T cells ratio and IL-4, IFN-γ levels in the peripheral blood of patients with pancreatic carcinoma. Methods Floweytometer was used to analyze the CD4-CD8-T cells ratio in the peripheral blood of patients with pancreatic carcinoma and the IL-4 ,IFN-γ levels were detected by ELISA. Results The ratio of CD4-CD8-T cell in CD3+ T cell from 25 pancreatic carcinoma patients was(4.2 ± 1.7) %, the ratio of CD4-CD8-T cell in CD3+T cell from 45 healthy person was(6.3 ± 2.6) %, there was significant deviation between the two groups(P < 0. 01). The IL-4 level of 25 pancreatic carcinoma patients was (86.3 ± 23.3) fg/L,the IL-4 level of 45 healthy person was (56.2 ± 9.2) fg/L,there was significant deviation between the two groups(P <0.01). The IFN-γ level of 25 pancreatic carcinoma patients was (16.4±4.8) fg/L before operation, the IFN-γ level of 45 healthy person was (27.4±3.8) fg/L,there was significant deviation between the two groups(P <0.01). The ratio of CD4-CD8-T cell in pancreatic carcinoma patient after operation was higher than before operation. It could be found negative correlation between CD4-CD8-T cells ratio and IL-4 level in pancreatic carcinoma patient,it could also be found positive correlation between CD4-CD8-T cells ratio and IFN-γ level in pancreatic carcinoma patient. In pancreatic carcinoma patient,the CD4-CD8-T cells ratio and IL-4 level was significant associated with clinical stage (P < 0.05), but no relationship with hisological differentiation (P>0.05), it could be found no relationship between IFN-γ level and clinical stage, hisoiogieal differentiation (P > 0.05). Conclusion The CD4±CD8±T cells ratio in the peripheral blood of patients is decreased,it may be participate in the carcinogenesis and development of pancreatic carcinoma by influence the IFN-γ levels.  相似文献   

7.
Objective To investigate the relationship between CD4-CD8-T cells ratio and IL-4, IFN-γ levels in the peripheral blood of patients with pancreatic carcinoma. Methods Floweytometer was used to analyze the CD4-CD8-T cells ratio in the peripheral blood of patients with pancreatic carcinoma and the IL-4 ,IFN-γ levels were detected by ELISA. Results The ratio of CD4-CD8-T cell in CD3+ T cell from 25 pancreatic carcinoma patients was(4.2 ± 1.7) %, the ratio of CD4-CD8-T cell in CD3+T cell from 45 healthy person was(6.3 ± 2.6) %, there was significant deviation between the two groups(P < 0. 01). The IL-4 level of 25 pancreatic carcinoma patients was (86.3 ± 23.3) fg/L,the IL-4 level of 45 healthy person was (56.2 ± 9.2) fg/L,there was significant deviation between the two groups(P <0.01). The IFN-γ level of 25 pancreatic carcinoma patients was (16.4±4.8) fg/L before operation, the IFN-γ level of 45 healthy person was (27.4±3.8) fg/L,there was significant deviation between the two groups(P <0.01). The ratio of CD4-CD8-T cell in pancreatic carcinoma patient after operation was higher than before operation. It could be found negative correlation between CD4-CD8-T cells ratio and IL-4 level in pancreatic carcinoma patient,it could also be found positive correlation between CD4-CD8-T cells ratio and IFN-γ level in pancreatic carcinoma patient. In pancreatic carcinoma patient,the CD4-CD8-T cells ratio and IL-4 level was significant associated with clinical stage (P < 0.05), but no relationship with hisological differentiation (P>0.05), it could be found no relationship between IFN-γ level and clinical stage, hisoiogieal differentiation (P > 0.05). Conclusion The CD4±CD8±T cells ratio in the peripheral blood of patients is decreased,it may be participate in the carcinogenesis and development of pancreatic carcinoma by influence the IFN-γ levels.  相似文献   

8.
Objective To investigate the effects of arginine enriched enteral nutrition (EN) on nu-tritional status and cellular immunity of severely burned patients. Methods Randomized, single blind, parallel and positive control investigation was employed in the study. Thirty severely burned patients were di-vided into enteral immune nutrition (EIN) group and EN group. Sixteen patients in EIN group received en-teral nutrition enriched with arginine, while the other 14 patients in EN group received standard enteral nu-trition. Nutritional support was continued for 14 days. Gastrointestinal reaction of patients in 2 groups was observed. Fasting venous blood was drawn from patients of both groups before receiving nutrition treatment and on the morning of 7th, 14th day of treatment. Level of serum protein, hepatic function parameters, renal function parameters, fasting-blood glucose, and subpopulations of T lymphocytes in peripheral blood were determined. Results (1) Incidence of gastrointestinal side effect in EIN group (25.0%) was close to that of EN group (21.4% , P>0.05). (2) Compared with pre-treatment days, levels of prealbumin and transferrin in serum of patients in 2 groups on 7th and 14th post-treatment days were significantly increased (P<0.05 or P<0.01), but there was no significant difference between 2 groups. The level of total serum protein on 14th day of treatment of patients was significantly increased in both groups, and that of EIN group (66±7 g/L)was significantly higher compared with that in EN group (64 ± 11 g/L, P<0.05). The level of serum albumin (29±5, 32±5 g/L, respectively) of patients in EIN group on 7th and 14th day of treat-ment were significantly higher than that (26±4 g/L, P <0.05) in pre-treatment days, however there was no significant difference in EN group. (3) There was no significant difference in respect of hepatic function, renal function, and fasting-blood glucose between pre-treatment and post-treatment periods in both groups (P>0.05). (4) The ratio of CD4+ , CD8+ on 14th day of treatment in EIN group was close to that of pre-treatment level. In EN group, cell percentage of CD4+ significantly decreased, while that of CD8+ significantly increased (P<0.05), and CD4+ was significantly higher [(56±8) %] in EIN group than that in EN group [(55±12) % , P <0.05]. In both groups, cell percentage of CD3+ was significantly higher than that in pre-treatment days (P<0.05), while there was no obvious change in CD4+/CD8+. Conclusions Arginine enriched enteral nutrition can effectively improve nutritional status and cellular immune function of burn patients.  相似文献   

9.
目的 观察骨髓间充质干细胞(MSCs)体外对1型糖尿病(T1DM)大鼠淋巴细胞表型及增殖能力的影响,探讨其抑制淋巴细胞增殖的机制.方法 分离、培养和鉴定大鼠MSCs,噻唑蓝(MIT)比色法观察该细胞对淋巴细胞增殖能力的影响,应用流式细胞术分析MSCs对植物血凝素(PHA)作用下淋巴细胞凋亡,周期水平和CD4+CD25+调节性T细胞亚群(CD4+CD25+Tregs)比例的影响.结果 大鼠MSCs表型为CD29+、CD90+、CD106+、CD34-、CD45-,对PHA刺激的淋巴细胞增殖有抑制作用,以淋巴细胞:MSCs为1∶1时(C组)抑制作用最强;共培养体系中,大部分淋巴细胞处于G0/G1期;C组淋巴细胞凋亡水平(58.05±0.89)%显著高于对照组(43.35±0.86)%(P<0.05);CD4+CD25+Tregs的比例C组(22.76±1.15)%显著高于对照组(5.80±0.68)%(P<0.05).结论 MSCs体外可显著抑制PHA刺激的T1DM大鼠淋巴细胞的增殖,其机制与CD4+CD25+Tregs比例增高密切相关.
Abstract:
Objective To observe the effects of bone marrow mesenchymal stem cells (MSCs) on the lymphocytes of rats with type 1 diabetes mellitus (T1DM) in vitro, and investigate the inhibitory effect of MSCs on lymphocytes proliferation and the underlying mechanism. Methods MSCs were isolated from SD rats, cultured in vitro, purified and then identified by testing the phenotypes with flow cytometry (FCM). The third-generation MSCs were planted in 24-well plates. After treated with mitomycin C, MSCs were co-cultured for 72 h with the T1 DM rat's lymphocytes activated by phytohemagglutinin (PHA). The proliferation of lymphocyte was measured by methyl thiazol tetrazolium (MTT) method. FCM analysis was done to investigate the apoptosis, cell cycle and the proportion of CD4+ CD25+ regulatory T cells of the T1 DM rat's lymphocytes after co-cultivation. Results The phenotypes of MSCs from normal SD rats were CD29 + , CD90 +, CD106 + , CD34-, CD45 -. MSCs obviously inhibited the lymphocyte proliferation stimco-culture system, most of the lymphocytes were arrested at G0/G1 phase. The apoptosis rate of lymphocytes (58.05 ± 0. 89)% in group C was increased significantly as compared with the control group (43.35± 0.86 ) % ( P < 0. 05 ) as well as the proportion of CD4 + CD25 + regulatory T cells (22.76 ± 1.15 ) % vs (5.80 ± 0. 68) %. Conclusion In vitro, MSCs can obviously inhibit the T1 DM rat' s lymphocytes proliferation stimulated with PHA via increasing the proportion of CD4 + CD25 + regulatory T cells.  相似文献   

10.
Objective To investigate the relationship between CD4-CD8-T cells ratio and IL-4, IFN-γ levels in the peripheral blood of patients with pancreatic carcinoma. Methods Floweytometer was used to analyze the CD4-CD8-T cells ratio in the peripheral blood of patients with pancreatic carcinoma and the IL-4 ,IFN-γ levels were detected by ELISA. Results The ratio of CD4-CD8-T cell in CD3+ T cell from 25 pancreatic carcinoma patients was(4.2 ± 1.7) %, the ratio of CD4-CD8-T cell in CD3+T cell from 45 healthy person was(6.3 ± 2.6) %, there was significant deviation between the two groups(P < 0. 01). The IL-4 level of 25 pancreatic carcinoma patients was (86.3 ± 23.3) fg/L,the IL-4 level of 45 healthy person was (56.2 ± 9.2) fg/L,there was significant deviation between the two groups(P <0.01). The IFN-γ level of 25 pancreatic carcinoma patients was (16.4±4.8) fg/L before operation, the IFN-γ level of 45 healthy person was (27.4±3.8) fg/L,there was significant deviation between the two groups(P <0.01). The ratio of CD4-CD8-T cell in pancreatic carcinoma patient after operation was higher than before operation. It could be found negative correlation between CD4-CD8-T cells ratio and IL-4 level in pancreatic carcinoma patient,it could also be found positive correlation between CD4-CD8-T cells ratio and IFN-γ level in pancreatic carcinoma patient. In pancreatic carcinoma patient,the CD4-CD8-T cells ratio and IL-4 level was significant associated with clinical stage (P < 0.05), but no relationship with hisological differentiation (P>0.05), it could be found no relationship between IFN-γ level and clinical stage, hisoiogieal differentiation (P > 0.05). Conclusion The CD4±CD8±T cells ratio in the peripheral blood of patients is decreased,it may be participate in the carcinogenesis and development of pancreatic carcinoma by influence the IFN-γ levels.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号